Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia. (Record no. 25077142)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02214 a2200685 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517042502.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201510s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1521-0103 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1124/jpet.115.225466 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Bonaventure, Pascal |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20151006 |
245 00 - TITLE STATEMENT | |
Title | Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The Journal of pharmacology and experimental therapeutics |
Date of publication, distribution, etc. | Sep 2015 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 471-82 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Animals |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Binding Sites |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Brain |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | CHO Cells |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Line |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cricetulus |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dopamine |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HEK293 Cells |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hypnotics and Sedatives |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice, Knockout |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Orexin Receptor Antagonists |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyridines |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Rats |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Rats, Sprague-Dawley |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sleep |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sleep Initiation and Maintenance Disorders |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sleep Stages |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sleep, REM |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Zolpidem |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Shelton, Jonathan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Yun, Sujin |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nepomuceno, Diane |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sutton, Steven |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Aluisio, Leah |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fraser, Ian |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lord, Brian |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Shoblock, James |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Welty, Natalie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chaplan, Sandra R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Aguilar, Zuleima |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Halter, Robin |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ndifor, Anthony |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Koudriakova, Tatiana |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rizzolio, Michele |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Letavic, Michael |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Carruthers, Nicholas I |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lovenberg, Timothy |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Dugovic, Christine |
773 0# - HOST ITEM ENTRY | |
Title | The Journal of pharmacology and experimental therapeutics |
Related parts | vol. 354 |
-- | no. 3 |
-- | p. 471-82 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1124/jpet.115.225466">https://doi.org/10.1124/jpet.115.225466</a> |
Public note | Available from publisher's website |
No items available.